Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Shares Outstanding (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of Shares Outstanding data on record, last reported at $67.8 million in Q4 2025.

  • For Q4 2025, Shares Outstanding rose 2.9% year-over-year to $67.8 million; the TTM value through Dec 2025 reached $67.8 million, up 2.9%, while the annual FY2025 figure was $67.8 million, 2.9% up from the prior year.
  • Shares Outstanding reached $67.8 million in Q4 2025 per PLSE's latest filing, roughly flat from $67.7 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $67.8 million in Q4 2025 and bottomed at $29.7 million in Q4 2021.
  • Average Shares Outstanding over 5 years is $51.9 million, with a median of $55.1 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: soared 48.1% in 2023, then rose 0.83% in 2024.
  • A 5-year view of Shares Outstanding shows it stood at $29.7 million in 2021, then rose by 25.3% to $37.2 million in 2022, then soared by 48.1% to $55.1 million in 2023, then rose by 19.55% to $65.9 million in 2024, then increased by 2.9% to $67.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $67.8 million in Q4 2025, $67.7 million in Q3 2025, and $67.3 million in Q2 2025.